Headquartered in Burlington, MA Fiscal year ends December NASDAQ: MASS 908devices.com
908 Devices is a chemical analysis company that designs and manufactures purpose-built handheld devices for point-of-need interrogation of unknown and invisible materials. The company's products serve vital health, safety, and defense technology applications, addressing the fentanyl and illicit drug crisis, toxic carcinogen exposure, and global security threats. Its product portfolio includes FTIR-based devices like VipIR and ProtectIR, as well as the recently acquired NIRLab near-infrared spectroscopy product line. The company's devices combine complementary analytical technologies, software automation, and machine learning to provide quick, actionable chemical identification answers. 908 Devices serves a diverse customer base including U.S. state and local law enforcement agencies, federal agencies, corrections agencies, and international law enforcement and security organizations. The company generates recurring revenue through service and contract arrangements alongside product sales, with an installed base of over 4,100 devices globally. Updated
Since March 2023, the Dow Jones Industrial Average has surged from 31,800 to 38,900. During that 12-month stretch, some stocks, like Nvidia (NASDAQ: NVDA | NVDA Price Prediction), have quadrupled, while others,…
These are five stocks for aggressive investors looking to get share count leverage on companies that have sizable upside potential. While not suited for all investors, they are not penny stocks with…
These five stocks that Cathie Wood's ARK funds own millions of shares of are perfect for aggressive investors who look to get share count leverage on companies that have sizable upside potential.
These five stocks that Cathie Wood's ARK funds own millions of shares of are perfect for aggressive investors who look to get share count leverage on companies that have sizable upside potential.
These are five stocks for aggressive investors looking to get share count leverage on companies that have sizable upside potential. While not suited for all investors, they are not penny stocks with…
These are five stocks for aggressive investors looking to get share count leverage on companies that have sizable upside potential. While not suited for all investors, they are not penny stocks with…
These are five stocks for aggressive investors looking to get share count leverage on companies that have sizable upside potential. While not suited for all investors, they are not penny stocks with…
Here are four companies expected to report quarterly results either Monday afternoon or Tuesday morning.
908 Devices is a chemical analysis company that designs and manufactures purpose-built handheld devices for point-of-need interrogation of unknown and invisible materials.
The Wall Street consensus 12-month price target for MASS is $13.38.
